Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity

J Am Heart Assoc. 2014 Apr 10;3(2):e000700. doi: 10.1161/JAHA.113.000700.

Abstract

Background: Inappropriate sinus tachycardia (IST) and postural tachycardia syndrome (POTS) are 2 disorders characterized by sinus tachycardia. It is debated whether the pathophysiology of IST and POTS results from abnormal autonomic regulation or abnormal sinus node function. We hypothesized that intrinsic heart rate (IHR) after autonomic blockade would be increased in patients with IST but not POTS.

Methods and results: We enrolled 48 POTS patients, 8 IST patients, and 17 healthy control (HC) subjects. Intravenous propranolol and atropine were given to block the sympathetic and parasympathetic limbs of the autonomic nervous system in order to determine the IHR. Patients with IST have a higher sympathetic contribution to heart rate when compared with POTS patients (31±13 bpm versus 12±7 bpm, P<0.001) and HC (8±4 bpm; P<0.001) and a trend to less parasympathetic contribution than POTS and HC (IST: 31±11 bpm versus POTS: 46±11 bpm versus HC: 48±11 bpm, ANOVA P=0.108). IHR was not significantly different between IST and either POTS or HC (IST: 111±11 bpm versus POTS: 108±11 bpm versus HC: 106±12 bpm, ANOVA P=0.237).

Conclusions: IST patients have more sympathetic tone when compared with either POTS or HC, but IST patients do not have abnormal sinus node automaticity. These data suggest that the treatment of IST and POTS should focus on sympatholysis, reserving sinus node modification for patients with continued debilitating symptoms after beta-blockade and possibly ivabradine.

Clinical trial registration url: http://clinicaltrials.gov/. Unique identifier: NCT00262470.

Keywords: autonomic nervous system; inappropriate sinus tachycardia; postural tachycardia syndrome; sinus node; sympathetic nervous system.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intravenous
  • Adult
  • Blood Pressure
  • Case-Control Studies
  • Female
  • Heart Rate* / drug effects
  • Humans
  • Male
  • Middle Aged
  • Parasympathetic Nervous System / drug effects
  • Parasympathetic Nervous System / physiopathology*
  • Parasympatholytics / administration & dosage
  • Periodicity
  • Postural Orthostatic Tachycardia Syndrome / diagnosis
  • Postural Orthostatic Tachycardia Syndrome / drug therapy
  • Postural Orthostatic Tachycardia Syndrome / physiopathology*
  • Sinoatrial Node / drug effects
  • Sinoatrial Node / innervation*
  • Sympathetic Nervous System / drug effects*
  • Sympathetic Nervous System / physiopathology*
  • Sympatholytics / administration & dosage
  • Tachycardia, Sinus / diagnosis
  • Tachycardia, Sinus / drug therapy
  • Tachycardia, Sinus / physiopathology*
  • Time Factors
  • Young Adult

Substances

  • Parasympatholytics
  • Sympatholytics

Associated data

  • ClinicalTrials.gov/NCT00262470